PAVmed (PAVM)

Special thanks to @Nasdaq for welcoming Joseph Virgilio to the team on the big screen in Times Square. We’re excited to have Joe join PAVmed Inc. to help drive the next phase of innovation and growth. #MedTech #Leadership

We’re pleased to welcome Joseph Virgilio as Senior Vice President and Chief Business Officer, Medical Devices at PAVmed Inc. Read the full announcement: lnkd.in/gPn4kAEf

Find yesterday's business update details here: lnkd.in/gxu3MZhs

Join us for a fourth quarter and full year 2025 Business Update conference call and webcast. Details here: lnkd.in/gvk4qeyv

Today is for her. The woman who makes her team better just by being in the room. Who opens doors—and holds them open for the next person. Who challenges ideas and helps everyone around her grow. We’re lucky to work alongside women like this every day. #InternationalWomensDay

As #NationalCancerPreventionMonth comes to a close, numbers like these reinforce our purpose. Our focus is clear: help change the trajectory of esophageal cancer by making early detection easy enough to fit into everyday care. #CheckYourFoodTube

Find today's Business Update details here: ir.pavmed.com/2025-11-13-PAV…

See you at #ACG2025! Detect Barrett’s esophagus earlier, expand access to screening, and deliver guideline-based care that prevents esophageal cancer before it starts. Connect with our team to learn how @EsoGuard_Test is making early detection easier.

We’re proud to announce that The @VerisHealth Cancer Care Platform will now be deployed across @OSUCCC_James, one of the nation’s leading comprehensive cancer centers, to enhance personalized care for patients undergoing systemic cancer therapy. ir.pavmed.com/2025-10-07-PAV…

We’re in San Diego for @MedTechCon hosted by @AdvaMedUpdate Connect with Lishan Aklog, MD and Shaun O'Neil as they join global leaders reimagining what’s possible in #MedTech. Here’s to collaboration, innovation, and the future of healthcare. #MTC25

We are pleased to welcome John R. Palumbo to our Board of Directors. "John is a highly accomplished executive whose 40 years of healthcare leadership experience spans early-stage ventures, growth-stage companies, and Fortune 100 corporations," said Lishan Aklog, MD, Lucid's Chairman and CEO. "His vast experience and deep expertise—which includes guiding early-stage companies through commercial growth—and vast network will be of great value as we approach transformational commercial milestones." ir.luciddx.com/2025-09-25-Luc…

This Friday September 5th join Lishan Aklog, MD, @LucidDiag CEO at the Cantor Fitzgerald Global Healthcare Conference. ir.luciddx.com/2025-08-27-Luc…

See the news: ir.pavmed.com/2025-08-26-PAV…

Find today's business update details here: ir.pavmed.com/2025-08-14-PAV…

Join us Business Update on August 14, 2025: lnkd.in/gAJQZvcV

Baltimore firefighter Steven Dorsey was the picture of health—until a subtle swallowing issue led to a devastating diagnosis: Stage 4 esophageal cancer. Now he's turning his fight into a mission: raising awareness among fellow first responders and urging departments nationwide to offer proactive screening with the @EsoGuard_Test, which detects esophageal precancer before it turns into cancer. Firefighters face a 62% higher risk of developing esophageal cancer compared to the general population. Steve’s story is a powerful reminder that early detection matters—and that risk factors and minor symptoms shouldn’t be ignored. We’re proud to stand with Steve and all who are fighting for better health outcomes for our first responders. Read the New York Post article here: nypost.com/.../firefighte… #EarlyDetection #Firefighter

Firefighter Steven Dorsey is on a mission to ensure firefighters know their risk, talk to their doctors, and get tested for esophageal precancer this #EsophagealCancerAwarenessMonth Steven has been with the Baltimore City Fire Department for 21 years, and was recently diagnosed with esophageal cancer. See his story here: youtu.be/9Ibiyj0HXhQ?si… Learn about hosting your own #CheckYourFoodTube precancer testing event: hhttps://www.esoguard.com/request-an-event

Today, on #NationalDoctorsDay, we celebrate the dedication, compassion, and expertise of physicians everywhere. Thank you for your tireless commitment to patients and progress. #ThankYouDoctors

We are pleased to announce that our ENVET-BE clinical utility study has been accepted for publication in Gastroenterology & Hepatology. "This study cements EsoGuard's critical role as a non-invasive tool to triage at-risk patients to invasive EGD, allowing the vast majority of patients recommended for esophageal precancer testing to avoid an invasive procedure. This is precisely what non-invasive triage tests are designed to do," said Lishan Aklog, MD, Lucid Diagnostics Chairman and CEO Read more: lnkd.in/gUXvGvhE #EarlyDetectionSavesLives

We're honored to team up with the @ssfdny for this week's #CheckYourFoodTube precancer screening event! Esophageal cancer is preventable, and we're dedicated to helping high-risk individuals access the @EsoGuard_Test